Biondvax制药 BVXV 深 沪
等待开盘 08-26 09:30:00 美东时间
1.36
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.36
- 总市值 496.66万
- 52周最高 118.00
- 市盈率 静 0.23
- 换手率 0.00%
- 52周最低 12.50
- 委 比 0.00%
- 总股本 365.19万
- 历史最高 6200.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 12.50
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
89bio has granted stock options to purchase 32,350 shares to two new employees under its 2023 Inducement Plan. The options, priced at the July 2, 2025 closing price, vest over four years with 25% after one year and the rest in 12 quarterly installments. 89bio focuses on developing therapies for liver and cardiometabolic diseases, with its lead candidate, pegozafermin, in Phase 3 for MASH and SHTG. The company is based in San Francisco.
07-09 20:05
BiondVax Pharmaceuticals Q2 EPS $(0.003) Up From $(2.00) YoY
BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.00) per share. This is a 99.85 percent increase over losses of $(2.00) per share from the same period last year.
2023-08-11 21:02
Nasdaq Grants BiondVax Extension to Regain Compliance With Listing Rules
JERUSALEM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceutical...
2023-08-02 04:01
BiondVax Announces First Quarter 2023 Financial Results and Provides Business Update
JERUSALEM, ISRAEL / ACCESSWIRE / May 15, 2023 / (via IBN) -- BiondVax Pharmaceu...
2023-05-16 04:45
Short Interest in BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) Drops By 52.0%
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Rating) was the recipient of a...
2023-04-18 04:43
关键比较：BiondVax Pharmicals（纳斯达克股票代码：BVXV）和ImmunityBio（纳斯达克股票代码：IBRX）
BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) and ImmunityBio (NASDAQ:IBR...
2023-04-15 18:23
Critical Comparison: BiondVax Pharmaceuticals (NASDAQ:BVXV) and ImmunityBio (NASDAQ:IBRX)
BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) and ImmunityBio (NASDAQ:IBR...
2023-04-15 18:23
BiondVax Pharmicals（纳斯达克股票代码：BVXV）的报道始于 StockNe
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV...
2023-04-05 13:42
股票分析师3月24日的新报道（AAU、ADAP、ADXS、AINC、AIRI、AMPE、BVXV、CAJ、CALC、CFMS）
Stock Analysts' new coverage for Friday, March 24th: StockNews.com assumed cove...
2023-03-25 02:54
Stock Analysts' New Coverage for March 24th (AAU, ADAP, ADXS, AINC, AIRI, AMPE, BVXV, CAJ, CALC, CFMS)
Stock Analysts' new coverage for Friday, March 24th: StockNews.com assumed cove...
2023-03-25 02:54
